(19)

(11)

EP 2 958 624 A1

(12)

(43) Date of publication: 30.12.2015 Bulletin 2015/53 (21) Application number: 14708330.7 (22) Date of filing: 18.02.2014

(51) International Patent Classification (IPC):  A61N 5/00(2006.01) A61K 31/137(2006.01) A61K 31/519(2006.01) A61K 31/675(2006.01) A61P 37/06(2006.01) A61K 38/13(2006.01) A61K 31/255(2006.01) A61K 31/661(2006.01) A61K 31/7076(2006.01) (86) International application number: PCT/IB2014/059067 (87) International publication number: WO 2014/128611 (28.08.2014 Gazette 2014/35)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME (30) Priority: 20.02.2013 US 201361766830 P (71) Applicants: Novartis AG 4056 Basel (CH) Kyorin Pharmaceutical Co., Ltd. Tokyo 101-8311 (JP)	(72) Inventors: GERGELY, Peter 4002 Basel (CH) KURIYAMA, Kazuhiko Shimotsuga-gun Tochigi 329-0114 (JP) (74) Representative: von Sprecher, Georg et al Novartis Pharma AG Patent Department 4002 Basel 4002 Basel (CH)